Abstract Details

Title Long-term efficacy, safety, and tolerability of three-times weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 5-year results of the Glatiramer Acetate Low-Frequency Administration (GALA) open-label extension study

Topic Multiple Sclerosis

Presentation(s) P6 - (-)

Poster/Presentation
Number 378

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Jessica K. Alexander, PhD (Jazz) PRESENTER	Jessica K. Alexander has received personal compensation for serving as an employee of Teva Pharmaceuticals. Jessica K. Alexander has received stock or an ownership interest from Teva Pharmaceuticals.
Hooman H. Beygi (Teva Pharmaceutical)	No disclosure on file
Peter Feldman	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��